RxDoctor Payments DataLook up a doctor →

Paul Babikian, MD

Neurology · Des Moines, IANPI 1912011859

Payments from drug & device makers

$107,370in general payments, 2019–2025

Across 567 payments — averaging $189.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$37K
  • Teva Pharmaceuticals USA, Inc.$29K
  • SK Life Science, Inc.$27K
  • Sunovion Pharmaceuticals Inc.$7K
  • Supernus Pharmaceuticals, Inc.$2K
  • Argenx US, Inc.$2K
  • plus $4K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)210$37,294
Teva Pharmaceuticals USA, Inc.85$28,703
SK Life Science, Inc.44$26,980
Sunovion Pharmaceuticals Inc.35$6,936
Supernus Pharmaceuticals, Inc.41$2,042
Argenx US, Inc.11$1,872
Biogen20$482
E.r. Squibb & Sons, L.L.C.4$451
Lundbeck LLC5$318
Novartis15$192
EMD Serono, Inc.4$180
MDD US Operations, LLC3$155
Genentech USA, Inc.3$154
Pfizer8$137
UCB, Inc.7$124
Amgen7$123
Eisai Inc.18$121
Otsuka America Pharmaceutical, Inc.1$117
Vanda Pharmaceuticals Inc.1$105
Adamas Pharmaceuticals, Inc.5$91
Lilly USA, LLC7$90
Acorda Therapeutics, Inc5$89
Amneal Pharmaceuticals LLC3$86
Biohaven Pharmaceuticals, Inc.1$83
TG Therapeutics, Inc.3$53
Impel Pharmaceuticals Inc.1$44
Sanofi3$43
Merz North America, Inc.2$36
Promius Pharma LLC2$35
Tanabe Pharma America, Inc.2$33
CSL Behring1$32
Alnylam Pharmaceuticals Inc.2$32
GE HealthCare1$29
Vertical Pharmaceuticals, LLC1$18
Kyowa Kirin, Inc.1$16
Medtronic1$16
Livanova USA, Inc.1$15
Upsher-smith Laboratories LLC1$15
Jazz Pharmaceuticals Inc.1$15
Bristol Myers Squibb1$14

How this compares

$107,370 in reported general payments places this provider in the 90th percentile of 132 neurology providers in Iowa.

See all neurology providers in Iowa →

Medicare billing

Part B allowed, 2024
$36,277
Medicare patients
275
Services billed
540

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Des Moines

See the full list for Iowa →

Where these figures come from

Is this you, or does something look wrong? →